Xenon Pharmaceuticals Inc (NASDAQ:XENE)

Delayed Data
As of Sep 17
 +0.90 / +5.29%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Xenon Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 31.00 and a low estimate of 24.00. The median estimate represents a +56.42% increase from the last price of 17.90.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Xenon Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 32.35%
Growthannually -100.00%


Growthquarterly 422.35%
Growthannually -19.52%
Key to the earnings and sales forecast charts.